Recombinant Collagen
Evonik, Essen, Germany, has released a clinical-grade version of its recombinant collagen-like protein platform for medical device development. Produced via sustainable fermentation, VECOLLAN ® offers high purity, batch-to-batch consistency and eliminates risks associated with animal-derived collagen. The new grade supports clinical studies beginning in 2026 and is suitable for applications in orthopedics, medical aesthetics, and sports medicine. Available in forms including sponges and hydrogels, the biomaterial offers tunable mechanical properties and compatibility with standard processing methods for tissue repair and regenerative devices.
Visit Here
